What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?
- PMID: 34756187
- PMCID: PMC8554481
- DOI: 10.1016/S1473-3099(21)00690-3
What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?
Conflict of interest statement
AWS is a member of The Lancet Commission on COVID-19, and a consultant to WHO. The author alone is responsible for the views expressed here and they do not necessarily represent the decisions, policies, or views of The Lancet Commission or WHO. I declare no competing interests.
Comment on
-
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.Lancet Infect Dis. 2022 Feb;22(2):183-195. doi: 10.1016/S1473-3099(21)00648-4. Epub 2021 Oct 29. Lancet Infect Dis. 2022. PMID: 34756186 Free PMC article.
References
-
- Singanayagam A, Hakki S, Dunning J, et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect Dis. 2021 doi: 10.1016/S1473-3099(21)00648-4. published online Oct 28. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
